radioligands

Novartis to File for Pluvicto Label Expansion After Promising Phase III Data
BioSpace
Fri, 04/5/24 - 11:37 am
Novartis
Pluvicto
prostate cancer
clinical trials
radioligands
Point and Lantheus’s Radioligand Drug Shows Effectiveness, but Not Enough for Wall Street
BioSpace
Mon, 12/18/23 - 10:14 pm
Point Biopharma
Lantheus Holdings
radioligands
prostate cancer
Eli Lilly
Novartis eyes first-line use of Lutathera after trial win
Pharmaphorum
Mon, 09/25/23 - 11:41 am
Novartis
radioligands
clinical trials
neuroendocrine tumors
Lutathera
Novartis expands in radio-oncology again with $1.3bn Artios alliance
Pharmaforum
Wed, 04/7/21 - 10:35 am
Novartis
radioligands
Artios Pharma
precision medicine
radio-oncology
Novartis dives even deeper into radioligands, notching licensing deal with iTheranostics for multiple compounds
Endpoints
Tue, 03/30/21 - 11:40 am
Novartis
radioligands
iTheranostics